While millions of Americans are set to receive larger tax refunds this filing season, experts warn that navigating a slew of new deductions and rules could lead to widespread confusion, errors, and potential delays.
Insurance broker Arthur J. Gallagher expands its European transport claims and U.S. employee benefits consulting through three targeted acquisitions, signaling aggressive growth despite recent stock pressure.
German authorities have apprehended two foreign nationals on suspicion of deliberately damaging state-of-the-art naval corvettes in Hamburg. The alleged acts, involving steel pellets and critical system tampering, raise serious security concerns amid heightened European tensions.
Ethereum's price faces headwinds following founder Vitalik Buterin's latest moves—a substantial charitable donation and a public reassessment of the blockchain's scaling roadmap—raising questions about market sentiment and the future of Layer 2 networks.
At least fourteen people died after a migrant dinghy collided with a Greek coast guard vessel near the island of Chios, reigniting scrutiny over EU border policies and migrant safety in the Eastern Mediterranean.
Goldman Sachs initiates coverage on Healthpeak Properties (DOC) with a neutral stance, highlighting improving occupancy trends and cash flow visibility in its senior housing segment, while the REIT moves forward with plans to spin off its senior housing assets into a new public entity.
Japanese pharmaceutical firm Shionogi & Co. reported robust nine-month results, with net income growth significantly outpacing revenue increases. The performance highlights the company's effective cost management and strategic portfolio shifts, though analysts caution that future growth hinges on key pipeline products and regulatory approvals.
After a year of muted returns and recent volatility, investors are scrutinizing whether European retail giant Ahold Delhaize's current share price presents a buying opportunity. Our analysis suggests a potential undervaluation, but competitive headwinds loom.
BASF shares (XTRA:BAS) have posted consistent gains across short and medium-term horizons, climbing over 9% in the past three months. This sustained momentum is forcing analysts and investors to re-examine the chemical giant's valuation amid a complex backdrop of European industrial demand and strategic restructuring.
U.S. soybean futures advanced Tuesday, buoyed by a rally in bean oil markets following new federal tax credit guidance. The gains come despite a mixed domestic crush report and softer European import figures, highlighting the complex dynamics in global oilseed markets.
The U.S. dollar's decline and a concentrated stock market rally around artificial intelligence are prompting global investors to reassess their exposure to American assets, shifting capital toward Europe, Asia, and traditional safe havens like gold.
As the Australian market braces for an RBA rate decision, a select group of technology and biotech firms are charting distinct paths, balancing innovation investment against shifting economic tides. We examine the prospects for Cogstate, Clinuvel Pharmaceuticals, and PYC Therapeutics.
As New York lawmakers consider tighter rules for prediction markets, platforms Polymarket and Kalshi are funding high-profile grocery giveaways, aligning their public image with Mayor Zohran Mamdani's campaign for affordable food.
Digital Currency Group CEO Barry Silbert views the recent sharp downturn in cryptocurrency markets not as a crisis, but as a necessary cleansing that will pave the way for the next major capital rotation. He reveals his conviction in Bitcoin, Ethereum, and a select few altcoins even as prices tumble.
The U.S. Small Business Administration will exclude lawful permanent residents from its flagship loan guarantee programs starting March 1, reversing recent policies and drawing sharp criticism from business advocates who warn it will stifle entrepreneurship.
GSK secures European approval to expand the use of its RSV vaccine Arexvy to a broader adult population, while launching a new long-acting biologic for severe asthma in the U.S. These strategic moves reinforce the company's focus on high-growth areas in vaccines and respiratory therapies.
French prosecutors have called on an appeals court to confirm a five-year ban on far-right leader Marine Le Pen holding public office, a move that could definitively bar her from the 2027 presidential race. The legal battle centers on fraud allegations involving European Parliament funds.
Chinese electric vehicle maker NIO has achieved a significant milestone by delivering its one-millionth vehicle, reporting a near-doubling of January sales year-over-year. The company is simultaneously accelerating its global footprint with new market entries in Central Asia and Europe, while rolling out major software upgrades to its existing fleet. This multi-front expansion comes as the global EV sector grapples with intensifying competition and shifting regulatory landscapes.
In a high-stakes appeal trial, French prosecutors have formally requested a five-year ban on Marine Le Pen holding elected office, a move that could definitively block the far-right leader's path to the 2027 presidential election over EU fund misuse allegations.
A landmark study from the Geneva Academy documents a global crisis in international humanitarian law, with civilians targeted on an industrial scale across multiple conflicts and major powers failing to enforce the rules.
